Tag : colombia

CCT Impact

Global Medical Cannabis Leader Khiron Opens New Zerenia™ Clinic and Retail Pharmacy in Colombia

CCT IMPACT Agent
Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV:KHRN)(OTCQX:KHRNF)(Frankfurt:A2JMZC), a global medical cannabis leader with core operations in Latin America and Europe, is pleased to announce the opening of a new Zerenia™ clinic location and a new retail pharmacy in Colombia. Following the announcement at the beginning of the year by the Government of Colombia on......
CCT Impact

Khiron Reports Q2 Results, 47% QoQ Increase in Medical Cannabis Revenues Driven by Colombia and Germany

CCT IMPACT Agent
Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, today announces its financial results for the quarter ended June 30, 2021. These filings are available for review on the Company’s SEDAR profile at www.sedar.com. All financial information in......
CCT Impact

Khiron Accelerates Entry into Mexico, Awarded High-THC Extract Export Quotas for Mexico by the Government of Colombia

CCT IMPACT Agent
Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN)(OTCQX: KHRNF)(Frankfurt: A2JMZC), a vertically integrated medical cannabis leader with core operations in Latin America and Europe, today announces regulatory and supply chain advances that accelerate Khiron’s entry into the Mexican market by several months. Leveraging the Company’s designation in Colombia as a National Strategic Project, Khiron......
CCT Impact

Khiron Partners with Colombia Cancer League to Deliver 3,000 Medical Cannabis Patient Consultations

CCT IMPACT Agent
Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN) (OTCQX: KHRNF)(Frankfurt: A2JMZC), a vertically integrated medical cannabis leader with core operations in Latin America and Europe, today announces, in partnership with the Colombia Cancer League, the launch of the “Cannabis: Medicine for Your Life” campaign throughout Colombia. In partnership with the Colombia Cancer League......
CCT Impact

Ikänik Farms Receives ISO-9001:2015 Certification for Cultivation and Laboratory Operations in Colombia

CCT IMPACT Agent
Ikänik Farms, Inc. (CSE: IKNK.U) (FSE: DFMA) (the “Company” or “Ikänik Farms“) is pleased to announce its wholly-owned, Colombian subsidiary Pideka SAS (“Pideka”), has received ISO-9001:2015 certification from SGS Colombia, for its administration, cultivation and laboratory operations. “We are extremely proud to have received the ISO-9001 accreditation, which continues to demonstrate our Pideka teams......
CCT Impact

Ikänik Farms Registers and Commercializes 6 CBD Products Eligible for Sale in Colombia, Ecuador, Bolivia & Peru

CCT IMPACT Agent
Ikänik Farms, Inc. (CSE: IKNK.U) (FSE: DFMA) (the “Company” or “Ikänik Farms“) is pleased to announce that its wholly owned, Colombian subsidiary Pideka SAS (“Pideka“), has completed the registration and commercialization process of six cannabis-based cosmetic products through the National Institute of Drug and Food Surveillance (INVIMA), the governing body in Colombia responsible new product registrations. “We......
CCT Impact

Khiron Announces Expansion of Small-Format Zerenia™ Clinics in Colombia Following Success of Initial Launch

CCT IMPACT Agent
Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, today announces that it will launch two additional small-format Zerenia™ clinics in Q1 2021. The new clinics, which follow on the successful launch of the Company’s first......
CCT Impact

Khiron Becomes First Company to Export High THC Medical Cannabis From Colombia

CCT IMPACT Agent
Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN), (OTCQX: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, announced that it has now successfully completed the import of its High THC medical cannabis product into Peru, with first prescriptions to be filled in December. With today’s announcement,......
CCT Impact

Khiron Medical Cannabis Products Now Qualify for National Insurance Coverage in Colombia

CCT IMPACT Agent
Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN), (OTCQX: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, announces that as a result of strong clinical evidence, the Company’s National Strategic Project status, and a directive from the Government of Colombia, its medical cannabis products and......
CCT Impact

Khiron to Open New Regional Zerenia™ Clinic in Medellin, Colombia

CCT IMPACT Agent
Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, today announces the opening of its first Zerenia clinic in Medellin, Colombia´s second largest city with reach to over 6 million residents in the region. Zerenia integrated medical......